Hyperglycaemia is common among critically ill patients and places significant impact on the clinical and economic outcome. In patients without a history of diabetes, prognosis may be even worse 1 . Systemic infection provokes a stress-induced hypermetabolic response through the activation of the hypothalamicadrenal axis, which in turn increases hepatic glucose production and inhibits insulin-mediated glucose uptake into skeletal muscles 2 . Therefore it can be hypothesised that bloodstream infection (BSI) could be associated with increased blood glucose levels.
The purpose of the study was to determine whether the extent or severity of hyperglycaemia upon onset of intensive care unit (ICU)-acquired BSI correlates with outcome in a well-defined heterogeneous population of severely ill patients. We also examined whether different patterns in blood glucose levels can be observed between survivors and non-survivors.
MATERIALS AND METHODS

Setting and patients
The subjects were 130 patients admitted to the medical, surgical, cardiosurgical or burn ICU of a tertiary care referral centre over a two-year period from 2003 through 2004, and whose ICU stay was complicated with a nosocomial BSI. 
SUMMARy
This study aimed to assess whether a relationship exists between hyperglycaemia and outcome in a mixed cohort of critically ill patients with nosocomial bloodstream infection (BSI), and to evaluate patterns of blood glucose levels between survivors and non-survivors.
A historical observational cohort study was conducted in the intensive care unit (ICU) of a tertiary care referral centre. One-hundred-and-thirty patients with a microbiologically documented ICU-acquired BSI (period 2003 to 2004) were included. For the study, morning blood glucose levels were evaluated from one day prior until five days after onset of BSI. The contribution of hyperglycaemia, divided in three subgroups (≥150 mg/dl, ≥175 mg/dl and ≥200 mg/dl), to in-hospital mortality was estimated by logistic regression. In-hospital mortality was 36.2%. Over the seven study days, no differences were found in daily morning blood glucose levels between survivors (n=83) and non-survivors (n=47). Nevertheless, the trend of blood glucose levels upon onset of BSI showed a remarkable increase in the non-survivors, whereas it decreased in the survivors. Hyperglycaemia (≥175 mg/dl and ≥200 mg/dl) was observed more often among the non-survivors. Multivariate logistic regression showed that APACHE II (P=0.002), antibiotic resistance (P=0.004) and hyperglycaemia (≥175 mg/dl) upon onset of BSI (P=0.017) were independently associated with in-hospital mortality, whereas a history of diabetes (P=0.041) was associated with better outcome.
Hyperglycaemia (≥175 mg/dl) upon onset of ICU-acquired BSI is associated with worse outcome in a heterogeneous ICU population. Patterns of morning blood glucose levels have only limited value in the prediction of the individual course.
Study design and measurements
Demographic, clinical, laboratory and physiological data were gathered retrospectively. A prospectively recorded database of BSIs was searched for ICU patients with microbiological and clinical evidence of ICU-acquired BSI. In patients who developed more than one episode of BSI, only the first episode was considered. Consistent with previous studies, morning blood glucose levels (MBGl) were evaluated, starting one day prior to onset of BSI (D-1) until five days after onset of BSI (D+5) 1, 3 . Individuals lacking information concerning MBGls, history of diabetes or hospital discharge status were excluded for analysis.
Definitions
Hyperglycaemia was defined as a BGl ≥150 mg/dl and further subdivided into three categories of severity: 1) ≥150 mg/dl, 2) ≥175 mg/dl and 3) ≥200 mg/dl according to the Surviving Sepsis Campaign guidelines and the American Diabetes Association 4,5 . Hypoglycaemia was defined arbitrarily as a blood glucose of ≤40 mg/dl in the absence of neuroglycopenic symptoms 6 . BSI was defined nosocomial as described in the Centres for Disease Control criteria 7 . Onset of BSI was defined as day zero (D0). Definitions of antimicrobial resistance are described elsewhere 8, 9 . Hospital mortality was assumed as the primary endpoint measure. Need for vasopressor/inotropic drugs was defined as haemodynamic instability, the need for ventilatory support as acute respiratory failure and the need for renal replacement therapy as renal failure 10 .
Statistics
Comparisons between groups were executed using the Student t and Mann-Whitney U, or the Chi square and Fisher's exact tests for continuous and categorical variables respectively. Univariate analysis indicated variables (P <0.10) to include in multivariate logistic regression, as well as those variables suspected to be clinically relevant. Age, Acute Physiology and Chronic Health evaluation (APACHe) II score, antibiotic resistance, history of diabetes, insulin treatment and hyperglycaemia (≥175 mg/dl at D0) were entered in the logistic regression model to control for confounders and to assess their independent relationship with in-hospital mortality. Statistical significance was defined at the 95% level. All tests were two-tailed. 
ReSUlTS
During the two-year study period, 152 ICU patients were identified with microbiological evidence for ICU-acquired BSI. After exclusion (n=22), 130 patients (54.7±19 years) were included in the study. Patient characteristics are listed in Table 1 .
In 33 patients (25.4%) multiple microorganisms were isolated from culture. A history of diabetes as a pre-existing co-morbidity ( 19 .1% if ≥200 mg/dl (P <0.001). Higher mortality rates were noted in hyperglycaemic non-diabetic compared to diabetic patients (66.6% vs. 33.4%), without statistical significance. Although, hypoglycaemic events were rare, they occurred more in non-survivors (1.2% vs. 6.4%, P=0.134). Although MBGls were not different between both groups, analysis of the trend showed an increase from D-1 onward to onset of BSI for non-survivors, whereas it decreased for survivors ( Figure 1) .
In univariate analysis, age, acute renal failure, APACHe II score, antibiotic resistance and hyperglycaemia (≥175 mg/dl and ≥200 mg/dl) were found to be associated with poor outcome. Multivariable analysis revealed that APACHe II (OR 1.12 per point increase; 95% CI, 1.04 to 1.20), antimicrobial resistance (OR 4.06; 95% CI, 1.56 to 10.58), and a BGl ≥175 mg/dl upon onset of BSI (OR 6.03; 95% CI, 1.38 to 26.33) were associated with an increased in-hospital mortality, whereas a history of diabetes (OR 0.23; 95% CI, 0.06 to -0.94) was associated with a lower in-hospital mortality rate. Age was of borderline significance (OR 1.03 per year increase; 95% CI, 1.00 to 1.05). Insulin treatment had no influence.
DISCUSSION
We investigated a series of adult critically ill patients with ICU-acquired BSI in order to verify whether the degree of hyperglycaemia upon onset of BSI was associated with increased mortality.
The results of the study demonstrated that significant increased mortality rates were observed according to the severity of hyperglycaemia (≥175 mg/dl). Although it was not the primary aim of the study, hyperglycaemic, non-diabetic patients were found to have a worse prognosis. A study of Umpierrez et al concluded that patients with a recent diagnosis of hyperglycaemia had substantial higher mortality rates and lower functional outcome than those with a pre-existing diabetes or normoglycaemia 1 . This was also confirmed by Grey et al who found that hyperglycaemia in a predominantly non-diabetic general surgery ICU population led to higher incidence of nosocomial infections 11 .
For all patients, median MBGls were evaluated in accordance with the Van den Berghe study 3 . Additionally, BGls were evaluated for several days in order to assess their respective evolution over time. Prior to the present study, a prospective study evaluating adherence and efficacy of an insulin protocol was conducted in our department in accordance with the Van den Berghe study 12 .
Consequently, the results obtained in the present study could be potentially influenced by the after-effects of this study. Although no strict BGl control algorithm was used during the present study, standard guidelines/instructions for BGl control were available stating that glycaemia should be maintained between 80 and 150 mg/dl. There were no alterations to these standard guidelines for BGl control during the study period. As well, no patients were co-enrolled in any other trial investigating BGl. Despite the fact that no strict insulin protocol was introduced to target glycaemia within specific pre-defined ranges, all median MBGls during follow-up were in line with these as recommended by the Surviving Sepsis Campaign guidelines 4 . The increased awareness among medical and nursing staff triggered by the publication of the leuven study, as well as the intensified educational programs about blood glucose control in the ICUs, may give a rational explanation for achieving this desirable performance. Systemic infection provokes a stress-induced hypermetabolic response through the activation of the hypothalamic-adrenal axis, which in turn increases hepatic glucose production and inhibits insulin-mediated glucose uptake into skeletal muscles 13 . Consequently, increased BGls are frequently observed in patients with BSI 14 . The purpose of this increased extracellular release of glucose is to support the inflammatory response of the host 13 . This metabolic alteration was clearly observed in the study cohort shown by an increase of BGls on the day positive blood cultures were sampled, although no statistically significant differences with respect to peak MBGls were observed between survivors and non-survivors ( Figure 1 ). With elevated BGls reported in septic patients, understanding glycaemic responses during critical illness is important. As mentioned above, following patterns of readily available parameters such as BGls may help to describe the clinical course of BSI. In a study by Gore et al, patients categorised with poor blood glucose control had significantly greater incidence of positive blood cultures, although this report failed to establish a cause and effect relationship 15 . The association between blood glucose control on the one hand and reduced infection morbidity rates on the other was already shown by others in cohorts of patients undergoing cardiac surgery procedures 16, 17 .
It is well known that critical illness contributes to the release of inflammatory mediators, which in turn are associated with pronounced insulin resistance in these patients 18 . Beneficial effects of suppression of these mediators remain hypothetical, although reduced levels have been associated with earlier resolution of sepsis and less predisposition to nosocomial BSI 2 . With salient progression made in the field, questions now arise as to whether blood glucose is a mediator or a marker of poor patients' outcome 19 .
Next, since it is known that insulin has anti-inflammatory properties, in patients with nosocomial BSI, insulin may have beneficial side-effects by curbing or even interrupting the inflammatory cascade 20, 21 . However, it is likely that the persistence of hyperglycaemia, rather than the effect or the dose of insulin that influences patients' outcome 22, 23 . Although the findings of the present study may not support the previous hypothesis, hyperglycaemia was shown to negatively impact patients' outcome, whereas insulin treatment was shown to have no influence. logistic regression could not demonstrate any beneficial effect regarding insulin treatment in the study cohort. The fact that a decrease in infectious complications can be related to the initiation of insulin, by improved glycaemic control, or to a combination of both remains a point of controversy and debate, and needs further elaboration.
This study has several potential limitations. First, we do not have information concerning the use of corticosteroids, enteral or parenteral nutrition therapy in the patients enrolled. Second, we are not able to provide additional information with respect to glycosylated haemoglobin A1C concentrations upon admission. This may have biased the results. Although prospective randomised trials may be preferred, this study is only possible to perform on a retrospective basis. On the other hand, this is the first study in the field reporting on data of such a well-defined cohort of ICU patients with unequivocal sepsis.
CONClUSIONS
Our results demonstrate that hyperglycaemia was associated with increased risk for adverse outcome in a heterogeneous ICU population with ICU-acquired BSI. The identification of the pattern of BGls only adds little information about the individual clinical course.
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